These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24381985)

  • 1. Serial screening for latent tuberculosis infection in healthcare workers in low-risk settings.
    Zellweger JP; Rieder HL
    Am J Respir Crit Care Med; 2014 Jan; 189(1):3-4. PubMed ID: 24381985
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
    El-Helaly M; Khan W; El-Saed A; Balkhy HH
    J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of tuberculin skin test and quantiferon-TB gold in tube test for diagnosis of latent tuberculosis infection in health care workers: A cross sectional study.
    Bozkanat E; Kaya H; Sezer O; Caliskan T; Kilic E; Ciftci F; Gumus S; Kartaloglu Z
    J Pak Med Assoc; 2016 Mar; 66(3):270-4. PubMed ID: 26968275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
    Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can we improve latent tuberculosis infection screening?].
    García-Gasalla M
    Med Clin (Barc); 2013 Apr; 140(7):305-6. PubMed ID: 23337448
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon γ-release assays for diagnosis of latent tuberculosis in healthcare workers in low-incidence settings: pros and cons.
    Pollock NR; McAdam AJ; Pai M; Nardell EA; Bernardo J; Banaei N; Mobo J
    Clin Chem; 2014 May; 60(5):714-8. PubMed ID: 24100806
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of interferon gamma release assay to assess latent tuberculosis infection among healthcare workers in Hong Kong.
    Tsang DN; Lai CK; Yam WC; Chan JW; Mok YW; Seto WH; Fung SC; Chu CM; Lam BH; Ng TK
    Hong Kong Med J; 2015 Dec; 21 Suppl 7():S22-5. PubMed ID: 26908269
    [No Abstract]   [Full Text] [Related]  

  • 13. [Risk of tuberculosis in healthcare workers: risk assessment and medical surveillance].
    Magrini A; Coppeta L; Somma G; Neri A; Gentili S; Fiocco G; Pietroiusti A
    Ig Sanita Pubbl; 2016; 72(2):137-43. PubMed ID: 27336958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Interferon-gamma release assay agreement with tuberculin skin test in pretransplant screening for latent tuberculosis in a high-prevalence country.
    Nassiri AA; Tabarsi P
    Iran J Kidney Dis; 2014 Sep; 8(5):432-3. PubMed ID: 25194415
    [No Abstract]   [Full Text] [Related]  

  • 15. Current approach to latent tuberculosis diagnosis and treatment among medical center occupational health physicians.
    Vinnard C; Linkin D; Behrman A
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1262-5. PubMed ID: 23143368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Interferon-gamma Release Assays in the Screening of Latent Tuberculosis Infection in Immigrant and Internationally Adopted Children.
    Méndez-Echevarría A; Sainz T; García-Hortelano M; Baquero-Artigao F; Mellado MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1141-2. PubMed ID: 26367809
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality control in QuantiFERON-TB gold in-tube for screening latent tuberculosis infection in health care workers.
    Igari H; Watanabe A; Ichimura Y; Sakurai T; Taniguchi T; Ishiwada N
    J Infect Chemother; 2017 Apr; 23(4):211-213. PubMed ID: 28094124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact tracing in low-incidence tuberculosis settings.
    van Leth F; Borgdorff M
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1566. PubMed ID: 22118163
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for latent tuberculosis before tumour necrosis factor antagonist therapy.
    Hewitt RJ; Singanayagam A; Sridhar S; Wickremasinghe M; Min Kon O
    Eur Respir J; 2015 May; 45(5):1510-2. PubMed ID: 25931493
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for latent tuberculosis before tumour necrosis factor antagonist therapy.
    Loebinger MR; Pozniak A
    Eur Respir J; 2015 May; 45(5):1512-3. PubMed ID: 25931494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.